Company Name: Genomic Health, Inc.
Genomic Health, Inc. develops molecular diagnostic tests that are used to determine how the patient will respond to certain therapies and the likelihood of recurrence for certain types of cancer. The company’s diagnostics include the Oncotype DX breast cancer test, the Oncotype DX colon cancer test and the Oncotype DX prostate cancer test.
Ticker Symbol: GHDX (NASDAQ)
Company Website: www.genomichealth.com
Headquarters: Redwood City, California